Research Progress in the Role of Tim3/galectin-9 in Hematological Malignancy--Review / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 1360-1364, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-888567
ABSTRACT
The incidence of hematological malignant tumor is increasing year by year, and seriously affecting the human health. In addition to the traditional radiation and chemotherapy, immunotherapy has achieved a certain effect in the treatment of blood tumor, but it is limited by exhaustion of CD8
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
CD8-Positive T-Lymphocytes
/
Hematologic Neoplasms
/
Galectins
/
Hepatitis A Virus Cellular Receptor 2
/
Immunotherapy
Limits:
Humans
Language:
Chinese
Journal:
Journal of Experimental Hematology
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS